MedTrace Logo

Mindfulness-based Relapse Prevention for Peer Workers

NCT07741825 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2026-08-07

No results posted yet for this study

Summary

Adapt and test the effectiveness of MBRP for substance use peer workers compared to a standard of care (referral to 12-step) control condition on substance use, relapse risk, and burnout among peers in a pilot hybrid type 1 trial.

The goal of this clinical trial is to learn if Mindfulness-Based Relapse Prevention can reduce substance use, relapse risk, and burnout among substance use peer workers. The objectives are to:

1. Identify the causes, consequences, and risk and protective factors for relapse among peer workers;
2. Identify peers' preferences related to MBRP content, structure, and delivery;
3. Adapt the MBRP intervention for peer workers; and
4. Assess the preliminary effectiveness and implementation outcomes of the adapted MBRP intervention.

Researchers will compare MBRP to referral to 12-step (standard of care) to see if MRBP works to reduce substance use, relapse risk, and burnout.

Participants will asked to:

* Participate in MBRP (8 weekly 2-hour virtual sessions)
* Complete 4 surveys assessing well-being outcomes
* Participate in 1 virtual interview about your experience

Conditions

  • Relapse/Recurrence
  • Substance Use (Drugs, Alcohol)
  • Burnout

Interventions

BEHAVIORAL

Mindfulness Based Relapse Prevention

MBRP for peer workers consists of 8 weekly 2-hour virtual sessions.

BEHAVIORAL

Standard of Care

Referral to 12-step programming

Sponsors & Collaborators

  • University of Texas at Austin

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-31
Primary Completion
2030-07-31
Completion
2030-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07741825 on ClinicalTrials.gov